ALL |
Acute lymphoblastic leukemia |
AML |
Acute myelogenous leukemia |
AR |
Allelic ratio |
AT/RT |
Atypical teratoid/rhabdoid tumor |
AYA |
Adolescent and young adult |
BDG |
Beta-D-glucan |
BMT CTN |
Blood and Marrow Clinical Trials Network |
Bu-Cy-Mel |
Busulfan-cyclophosphamide-melphalan |
Bu-Flu |
Busulfan-fludarabine |
CAR-T |
Chimeric antigen receptor T cell |
CCL |
Cancer Control |
CEM |
Carboplatin-etoposide-melphalan |
cGVHD |
Chronic GVHD |
CMV |
Cytomegalovirus |
CNS |
Central nervous system |
COG |
Children’s Oncology Group |
CT |
Cellular Therapy and Stem Cell Transplantation
Committee |
CTEP |
Cancer Therapy Evaluation Program |
DFS |
Disease free survival |
EBV |
Epstein Barr virus |
EFS |
Event free survival |
FACT |
Foundation for the Accreditation of Cellular
Therapy |
FDA |
U.S. Food and Drug Administration |
FLT3 |
Fms-like tyrosine kinase |
GI |
Gastrointestinal |
GVHD |
Graft-versus-Host disease |
GVL |
Graft-versus-leukemia |
HCT |
Hematopoietic cell transplantion |
HLA |
Human leukocyte antigen |
HR |
Hazard ratio |
IFD |
Invasive fungal disease |
IgH |
Immunoglobulin heavy chain |
JMML |
Juvenile myelomonocytic leukemia |
KIR |
Killer immunoglobulin receptor |
LD IL-2 |
Low dose interleukin-2 |
MAGIC |
Mount Sinai Acute Graft versus Host Disease International
Consortium |
MDS |
Myelodysplastic syndrome |
MRD |
Minimal residual disease |
MUD |
Matched unrelated donor |
NB |
Neuroblastoma |
NGS |
Next-generation sequencing |
OS |
Overall survival |
PTCTC |
Pediatric Transplant and Cellular Therapy
Consortium |
PTCy/Tac/MMF |
Post-HCT cyclophosphamide with tacrolimus and
mycophenolate |
PTLD |
Post-transplant lymphoproliferative disorder |
SOT |
Solid organ transplant |
TBI |
Total body irradiation |
TCR |
T-cell receptor |
TKI |
Tyrosine kinase inhibitor |
TRM |
Transplant related mortality |
UCB |
Umbilical cord blood |
V[D]J |
Variable, diversity, and joining |
VOD/SOS |
Veno-occlusive disease/sinusoidal obstructive
syndrome |
VSTs |
Virus-specific T-cells |
131I-MIBG |
131I-meta-iodobenzylguanidine |